ANGO Net Income
-$32.94MTTM · USD
Period ending:
ANGO FY Net IncomeUSD
$61.34M-$184.35M
2001-05-312026-05-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
ANGO net income history
Total earnings after all expenses, taxes, and interest. The available annual fiscal periods series contains 26 observations from May 31, 2001 to May 31, 2026.
| Period ending | Net Income (USD) |
|---|---|
| -36,742,000 | |
| -33,993,000 | |
| -184,349,000 | |
| -52,442,000 | |
| -26,547,000 | |
| -31,548,000 | |
| -166,787,000 | |
| 61,340,000 | |
| 16,335,000 | |
| -7,052,000 | |
| -43,590,000 | |
| -3,388,000 | |
| 2,347,000 | |
| -1,211,000 | |
| -5,183,000 | |
| 8,117,000 | |
| 12,312,000 | |
| 9,932,000 | |
| 10,889,000 | |
| -9,127,000 | |
| 6,866,000 | |
| 4,548,000 | |
| 3,143,000 | |
| 1,186,000 | |
| 1,009,000 | |
| 343,000 |
Compare net income
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) net income
- Bridgebio Pharma Inc (BBIO) net income
- Brightspring Health Services Inc (BTSG) net income
- Madrigal Pharmaceuticals Inc (MDGL) net income
- Ensign Group Inc (ENSG) net income
- Glaukos Corp (GKOS) net income
- Vaxcyte Inc (PCVX) net income
- Krystal Biotech Inc (KRYS) net income
All ANGO financial metrics · ANGO stock overview · How to interpret financial metrics
